New study aims to sharpen brain tumor tracking with PET imaging

NCT ID NCT07159607

Recruiting now Knowledge-focused Sponsor: LMU Klinikum Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 23 times

Summary

This study is looking at how well PET scans can track brain tumor changes in people with IDH-mutant gliomas (a type of brain cancer). Researchers want to see if PET scans can tell the difference between tumor growth and treatment side effects better than standard MRI. About 100 adults from two hospitals in Germany and Austria will have their routine PET and MRI data collected and compared over time. The goal is to improve future guidelines for monitoring these tumors, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

LMU Hospital
RECRUITING

Munich, Bavaria, 81377, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••
Medical University of Vienna
RECRUITING

Vienna, 1090, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA)